Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general population.
about
Capsule commentary on Ingebrigsten et al., Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general population.Dual bronchodilator therapy with aclidinium bromide/formoterol fumarate for chronic obstructive pulmonary disease.Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices.Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related.Adherence to Maintenance Medications among Older Adults with Chronic Obstructive Pulmonary Disease. The Role of Depression.Ethnic Differences in Persistence with COPD Medications: a Register-Based Study.Guiding Principles for the Use of Nebulized Long-Acting Beta2-Agonists in Patients with COPD: An Expert Panel Consensus.The impact of pharmacist-managed clinic on medication adherence and health-related quality of life in patients with COPD: a randomized controlled study.Adherence to inhaled therapies of COPD patients from seven Latin American countries: The LASSYC study.Poor adherence to chronic obstructive pulmonary disease medications in primary care: Role of age, disease burden and polypharmacy.Do not do in COPD: consensus statement on overuse.Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD.Adherence to COPD treatment in Turkey and Saudi Arabia: results of the ADCARE study.Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study.
P2860
Q34826351-415F99D7-EFD7-4382-BAE4-1909C2B14AE5Q38586322-AFE4E745-4316-4EE8-B0E0-C2F37F92B469Q38842452-3586D8AC-1D3D-4F23-B870-63709E522936Q39459241-140CD016-7029-47C0-89CA-33392E504E68Q39663376-396D4CA8-E043-4C50-BA9C-2320C07FD7E9Q40242618-C35DE50C-0FF6-44EB-8B31-B22ED1821391Q41441617-413100E1-CB74-427B-8C70-7EEB02720678Q42417568-27B63989-2BF8-4DDA-9A41-FA9559D28050Q47103157-7A6074C3-6165-4370-9A13-B6F0DEE7AA07Q48213382-DC53844C-9D3D-4841-B79D-0E5F5650FADAQ49625748-056FCCF7-823B-481F-AC40-A77835EE2D60Q55120067-DCAB12C7-3147-462D-ADB6-C9889E76BF95Q55228694-E9471F23-AE68-4F9C-B9D8-67A6C057C34BQ55264356-F1F7E4AD-6339-4F77-986C-69D36AC42F97
P2860
Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general population.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Low use and adherence to maint ...... ase in the general population.
@ast
Low use and adherence to maint ...... ase in the general population.
@en
Low use and adherence to maint ...... ase in the general population.
@nl
type
label
Low use and adherence to maint ...... ase in the general population.
@ast
Low use and adherence to maint ...... ase in the general population.
@en
Low use and adherence to maint ...... ase in the general population.
@nl
prefLabel
Low use and adherence to maint ...... ase in the general population.
@ast
Low use and adherence to maint ...... ase in the general population.
@en
Low use and adherence to maint ...... ase in the general population.
@nl
P2093
P2860
P50
P1476
Low use and adherence to maint ...... ase in the general population.
@en
P2093
Jacob L Marott
Peter Lange
Truls S Ingebrigtsen
P2860
P2888
P356
10.1007/S11606-014-3029-0
P577
2014-09-23T00:00:00Z
P6179
1050209366